Article
Increased blood CSF3R+ myeloid-derived suppressor cell is a predictor for breast cancer recurrence
1 Jan 2024
Abstract excerpt
Early detection of cancer recurrence using specific biomarkers remains a clinically unmet need, although methodologies for monitoring tumor markers, cell-free DNA, and circulating tumor cells have been established for decades.Tumor recurrence develops in metastatic or dormant cancer cells under continuous immune surveillance.Alterations in the population and function of immune cells may contribute to cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
